Abstract: Organic electrolytic solutions are provided. One solution includes a lithium salt, an organic solvent including a first solvent having high permittivity and a second solvent having a low boiling point, and a phosphate compound. By using the phosphate based compound, the organic electrolytic solution and the lithium battery including the organic electrolytic solution are flame resistant and have excellent charge/discharge properties. As a result, the lithium battery is highly stable and reliable and has good charge/discharge efficiency.

Abstract: Provided are a polyvinyl pyrrole host material emitting highly efficient phosphorescence, a luminescent layer using the material, and an organic electroluminescent display device. The polyvinyl pyrrole host material shows highly efficient luminescence having improved energy transfer, and thus is useful for an organic electroluminescent display device and other various light emitting devices.

Abstract: A method for imaging includes receiving a first three-dimensional (3D) image of a vicinity of an organ within a body of a subject and creating a geometrical model of a tubular structure in the first 3D image in the vicinity of the organ. An invasive probe is inserted into the organ, and a second 3D image containing the organ is captured using the invasive probe. One or more points are located on a surface of the tubular structure using the invasive probe, and the second 3D image is registered with the first 3D image by matching the one or more points to the geometrical model.

Abstract: Provided are a polyvinyl pyrrole host material emitting highly efficient phosphorescence, a luminescent layer using the material, and an organic electroluminescent display device. The polyvinyl pyrrole host material shows highly efficient luminescence having improved energy transfer, and thus is useful for an organic electroluminescent display device and other various light emitting devices.

Abstract: A bioengineering, in particular to develop novel probiotic preparations based on Bacillus-strain bacteria, which can be used for preventing and treating infectious diseases and disbiosis of a human being, farm animals and birds. The novel strains of B. subtilis 07 (VKPM N B-8611) and B. licheniformis 09 (VBKPM N B-8610) exhibit a broad spectrum of antagonistic activity, high proteolytic and amylase activity and a distinct ability in terms of a lysozim production. Such strains do not compete with each other but enter into synergistic relations in the form of an increased antagonistic action of the biopreparation. The inventive biopreparation comprises the B. subtilis 07 BKPM N B-8611 and B. licheniformis 09 BKPM N B-8610 strains and a protective medium. Such biopreparation can also contain a solvent and/or filler and exhibits an increased antagonistic activity with respect to a wide range of pathogenic and opportunistic pathogenic microorganisms and a resistance to a quite number of antibiotics.

Abstract: The invention relates to novel 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)-3-alkoxycarbonyl indole derivatives of general formula (I) and to pharmaceutically acceptable salts thereof exhibiting antiviral activity and to a method for the production thereof. The compounds can be used for treating and/or preventing such viral diseases as pig and bird flu. The invention also relates to a method for producing the compounds of general formula (I), wherein X is hydrogen, chlorine or iodine, n=1 or 2, R3 is C1-C5 alkyl, Alk is a C1-C6 alkyl group, R1 and R2 are independently selected from C1-C4 alkyl, mainly methyl, or the NR1R2 group means groups of formula (II).

Abstract: The invention relates to novel antiviral compounds of general formula (I), where B is —N(R)2 or —O—(CH2)nN(R)2 groups, in which n is a whole number selected from 0, 1, 2, 3 and 4, each R is independently selected from C1-4 alkyl and can be identical or different, or both groups R together with a nitrogen atom, to which they are bonded, form a 5-6-membered heterocyclic ring containing 1-2 heteroatoms selected from nitrogen, oxygen and sulphur, such as pyrrolidine, piperidine, piperazine, morpholine or thyomorpholine, at which each of above-mentioned heterocyclic rings can be substituted by C1-4 alkyl, phenyl, benzyl, phenetyl, a carbonylamino —COOC1-4 alkyl group or the carbonylamino —COOC1-4 alkyl group and phenyl, which also can be substituted and have substituents selected from halogen, C1-4 alkyl, C1-4 alkoxy, and alkyl in said groups can be linear or branched; R1 is C1-4 alkoxy, phenyl optionally substituted by C1-4 alkyl or C1-4 alkoxy, halogen atoms, naphthyl; R2 is C1-4 alkyl, —S-phenyl, —S-benzyl, —O-

Abstract: An organic electrolytic solution is provided which includes a lithium salt, an organic solvent including a first solvent having high permittivity and a second solvent having a low boiling point, and a phosphine oxide compound The phosphine oxide compound imparts flame resistance and good charge/discharge properties, thereby producing a lithium battery that is highly stable and reliable and that has good charge/discharge efficiency.

Abstract: An organic electrolytic solution includes a lithium salt; an organic solvent including a high dielectric constant solvent and a low boiling point solvent; and an additive of a hetero ring compound including a cyano group and an alkenyl group as substituents. The organic electrolytic solution and the lithium battery employing the organic electrolytic solution suppress the reduction decomposition of a polar solvent to improve the capacity retention ratio of the battery. Thus, the charge/discharge efficiency and lifespan of the battery can be improved.

Abstract: An organic electrolyte solution includes a lithium salt; an organic solvent including a high permittivity solvent and a low boiling solvent; and a vinyl-based compound represented by Formula 1 below, wherein m and n are each independently integers of 1 to 10; X1, X2, and X3 each independently represent O, S, or NR9; and R1, R2, R3, R4, R5, R6, R7, R8, and R9 are represented in the detailed description. The organic electrolyte solution of the present invention and a lithium battery using the same suppress degradation of an electrolyte, providing improved cycle properties and life span thereof.

Abstract: An organic electrolyte solution including: a lithium salt; an organic solvent including a high permittivity solvent and a low boiling solvent; and a silane-based compound represented by Formula 1 below: In Formula 1, m and n are each independently integers of from 1 to 30; and R1, R2, R3, R4, R5, R6, R7, and R8 are represented in the detailed description of the present invention. The organic electrolyte solution can be included in a lithium battery, so as to suppress the degradation of an electrolyte, and to improve cycle properties and life span of the battery.

Abstract: An organic electrolytic solution for a lithium-sulfur battery that provides high discharge capacity and longer cycle life to the battery, and a lithium-sulfur battery including the organic electrolytic solution are provided.

Abstract: An organic electrolytic solution and a lithium battery employing the same are provided. The organic electrolytic solution includes: a lithium salt; an organic solvent containing a high dielectric constant solvent and a low boiling point solvent; and a carbonate or oxalate derivative having at least one substituted or unsubstituted cyano group. The organic electrolytic solution and the lithium battery employing the same have improved reductive decomposition stability, thereby decreasing an irreversible capacity after a first cycle and improving the charge/discharge efficiency and lifespan of the battery. The lithium battery has non-varying chemical properties at room temperature and a uniform thickness after standard charging, and thus has high reliability.

Abstract: An organic electrolytic solution and a lithium battery employing the same are provided. The organic electrolytic solution includes: a lithium salt; an organic solvent containing a high dielectric constant solvent and a low boiling point solvent; and a dicarboxylic acid derivative having at least one substituted silyl group. The organic electrolytic solution and the lithium battery employing the same have improved reductive decomposition stability, thereby decreasing an irreversible capacity after a first cycle and improving the charge/discharge efficiency and lifespan of the battery. The lithium battery has non-varying chemical properties at room temperature and a uniform thickness after standard charging, and thus has high reliability.

Abstract: An anticancer agent containing platinum preparation, humic substances, water and sodium chloride. Potassium tetrachloroplatinate is used as a platinum compound and lignohumic acid ammonium salts are used as humic substances taken in the following ratio of components per 1 ml of solution: lignohumic acid ammonium salts 0.18-0.22 mg potassium tetrachloroplatinate 0.020-0.040 mg sodium chloride isotonic solution 0.97-0.99 ml distilled water up to 1.

Abstract: A method for imaging includes receiving a first three-dimensional (3D) image of a vicinity of an organ within a body of a subject and creating a geometrical model of a tubular structure in the first 3D image in the vicinity of the organ. An invasive probe is inserted into the organ, and a second 3D image containing the organ is captured using the invasive probe. One or more points are located on a surface of the tubular structure using the invasive probe, and the second 3D image is registered with the first 3D image by matching the one or more points to the geometrical model.

Abstract: An organic electrolytic solution for a lithium-sulfur battery that can improve discharge capacity and cycle life of the battery, and a lithium-sulfur battery using the organic electrolytic solution are provided. The electrolytic solution includes a lithium salt, an organic solvent, and further a phosphine sulfide-based compound represented by formula (I) below: wherein R1, R2 and R3 are the same or different from each other, and each represents one selected from the group consisting of a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C1-C30 alkoxy group and a substituted or unsubstituted C8-C30 aralkenyl group. The electrolytic solution including the phosphine sulfide-based compound represented by Formula (I) can suppress production of lithium sulfides so that a reduction in battery capacity can be prevented.

Abstract: A system and method for determining the concentration of analytes of interest in complex matrices is provided. According to one aspect of the present invention, near-infrared analytical radiation is generally directed onto a portion of a specimen containing the analyte of interest. A wavelength of the analytical radiation is scanned over the specimen over a broad range of frequencies and over a short duration of diagnostic time. A spectrum of radiation is transmitted through, reflected from or scattered from the specimen and collected by a detector. The concentration of the analyte of interest in the specimen is determined by the radiation collected by the detector.

Abstract: The present invention relates to an electrolytic solution for a lithium battery and a lithium battery using the same. The organic electrolytic solution includes a lithium salt, a mixed organic solvent comprising a high dielectric constant solvent and a low boiling-point solvent, and an additive. The additive used in the electrolytic solution is a heterocyclic compound of Formula (1): where R1, R2 and R3 may each independently be a C1-C10 linear or branched alkyl group; R4 may be a C1-C10 linear or branched alkylene group; X may be a heterocyclic ring containing N and O whereby a tetraallkyl orthosilicate functional group may be linked to N. The lithium battery using the organic electrolytic solution of the present invention is highly reliable and maintains a constant thickness during a charge/discharge cycle.

Abstract: The present invention relates to a photosensitive diagnostic device configured to project an optical signal, capture reflected portions of the optical signal, and convert the captured portions of the optical signal into an electrical signal indicative of characteristics of a sample analyzed by the device. In accordance with one embodiment, a photosensitive diagnostic device comprises an illumination source and a detector. The illumination source comprises an output face configured to project an optical signal characterized by at least one diagnostic frequency. The detector comprises a photosensitive input face configured to capture reflected portions of the optical signal. The photosensitive input face of the detector is further configured to convert the captured portions of the optical signal into one or more electrical signals at least partially representing a degree of change in the diagnostic frequency of the optical signal.